Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Altria invested big in Cronos but the stock faded in the months that followed. With all that cash on hand, CRON stock is ready to grow.

Dumping Cronos Group Stock Is a Big Mistake

CRON stock has been popular because Cronos hasn't been on a rampant acquisition spree. But, that could be about to change.

Looming Goodwill Growth Makes CRON Stock Tough to Handicap

Although Cronos Group stock is backed by some positive fundamental drivers, the inability for the company -- or the sector as a whole -- to actualize some of this potential has scared off investors.
The post Here’s Why Cronos Stock Is Heading To $9 Per Share appeared first on InvestorPlace.

Here’s Why Cronos Stock Is Heading To $9 Per Share

TORONTO, Aug.  26, 2019  (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”) (TSX: CRON) (Nasdaq: CRON), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer of Cronos Group, will speak at Barclays Global Consumer Staples Conference at 10:30 a.m. ET in Boston, MA.

Cronos Group Inc. CEO, Mike Gorenstein, to Present at Barclays 2019 Global Consumer Staples Conference

Aurora Cannabis

Aphria

Canopy Growth

CannTrust Holdings

Curaleaf Holdings, Inc.

GW Pharmaceuticals

Tilray Brands

Here's why marijuana stock market caps have gone up in smoke.

These 10 Pot Stocks Have Lost Nearly $21 Billion in Aggregate Value in 4 Months

TORONTO, Aug.  23, 2019  (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) has entered into a credit agreement (the “Credit Agreement”), as administrative agent and lender, with Cronos Growing Company Inc. (“Cronos GrowCo” or “GrowCo”), as borrower, in respect of a $100 million secured non-revolving term loan credit facility (the “Credit Facility”).

Cronos Group Inc. Enters into Credit Agreement with Cronos Growing Company Inc.

CRON stock just released its second-quarter earnings and the price of CRON stock has trended lower since then.
The post What Investors Should Know From Cronos Stock’s Earnings Release appeared first on InvestorPlace.

What Investors Should Know From Cronos Stock’s Earnings Release

Despite plunging valuations, these well-known marijuana stocks are worth avoiding.

3 Popular Pot Stocks At or Near Their 2019 Lows That Still Aren't Worth Buying

Hint: Most are years away from delivering consistent profits. But there's one notable exception.

When Will the Big Canadian Cannabis Producers Become Profitable?

Cara Therapeutics

HEXO Corp

OrganiGram Holdings Inc.

Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
The post 10 Marijuana Stocks That Could See 100% Gains, If Not More appeared first on InvestorPlace.

10 Marijuana Stocks That Could See 100% Gains, If Not More

The cannabis sector is poised to break out of the summer doldrums -- and CRON stock will lead the charge.
The post Watch Cronos Stock Continue to Grow Over the Coming Weeks appeared first on InvestorPlace.

Watch Cronos Stock Continue to Grow Over the Coming Weeks

These cannabis stocks all offer at least 36% upside.

3 Marijuana Stocks You Should Buy, According to This 124-Year-Old Wall Street Firm

Here's what needs to happen if these marijuana stocks are going to come bouncing back.

Have These Tumbling Cannabis Stocks Hit Bottom Yet?

This high-yield dividend stock should outperform during a market downturn.

1 Rock-Solid Marijuana Stock to Buy in a Recession

Green Thumb Industries Inc.

Piper Jaffray likes several U.S. cannabis stocks and one Canadian pot stock better than Aurora.

Forget Aurora Cannabis, a Top Analyst Says Buy These 5 Pot Stocks Instead

CRON stock is not without its risks. But recent bullish commentary from Piper Jaffray highlights all the reasons long-term investors may need to take a closer look at Cronos.

3 Reasons to Love Cronos Stock

Cannabis stocks got a boost on Tuesday after a major Wall Street firm initiated bullish coverage of Cronos Group Inc (NASDAQ: CRON).

Piper Jaffray Initiates Coverage Of Cronos, Says Stock 'Warrants A Premium Valuation'

Because marijuana investments like Cronos Group stock are so sensitive to news items, they’re prone to severe volatility. However, the opposite is also true, which makes this discounted price point a compelling proposition.

Narrative-Driven Cronos Group Stock Finally Has Good News

Altria

I wouldn’t be surprised if the recent $300 million purchase of Los Angeles-based Redwood Holding Group, a manufacturer of hemp-derived cannabidiol (CBD) infused skincare and other hemp-derived products, was an idea hatched by Altria. 
The post Cronos Stock Still Looks Like a Brilliant Investment for Altria appeared first on InvestorPlace.

Cronos Stock Still Looks Like a Brilliant Investment for Altria

It was a rough month for marijuana stocks.

Why Aurora Cannabis, Cronos Group, and Canopy Growth Plunged in July

Each of these seven marijuana stocks can teach a valuable lesson into how to use technical analysis to identify important levels.

Marijuana Stocks With Critical Levels to Watch

Marijuana stock investor have been dealing with negative investor sentiment for several months now. However, a new Cronos CBD deal and a huge positive reaction to Aphria earnings may have turned the tide.

Cronos and Aphria Stock Shift Marijuana Investing Sentiment

Is  (CRON) Outperforming Other Finance Stocks This Year?

Has Cronos Group (CRON) Outpaced Other Finance Stocks This Year?

Cronos Group may have blown Wall Street's forecasts out of the water, but that doesn't tell the full story.

Sorry, Folks, but Cronos Group's Second-Quarter Results Aren't That Impressive

Cronos Group's latest results don't have implications just for Cronos.

News for Cronos Group Stock (CRON)